Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Long-Acting Lanreotide as a Volume Reducing Treatment of Polycystic Livers
Brief Summary: To assess the efficacy of lanreotide in controling total liver volume in patients with polycystic livers this study will be performed. A minimum of 38 patients will be recruited and randomized (1:1) to receive either verum or placebo. Lanreotide is already used in other disease states and found to be safe and non-toxic.